DBD - Laboratory and Epidemiology Support Services for Pneumonia, Streptococcus, and Atypical Bacteria

The contract covers laboratory and epidemiology support services specifically focused on pneumonia, Streptococcus, and atypical bacteria. It is structured with a base performance period starting on September 29, 2024, and running through September 28, 2025, followed by four one-year option periods extending the contract through September 28, 2029. The total value of the contract across all tasks is $23 million, reflecting the anticipated scope and scale of work required. Administered by the Centers for Disease Control and Prevention, this engagement seeks to enhance public health efforts through specialized scientific and technical support. Key points of contact include Theresa Kanter, serving both as the program point of contact and designated contracting officer. While some solicitation details such as set-aside status, NAICS code, and specific location remain unspecified, the contract’s emphasis is on robust laboratory and epidemiological services to address important bacterial respiratory infections.